We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Needle-Free Intrauterine Anesthesia Technique Reduces Pain During IUD Insertion

By HospiMedica International staff writers
Posted on 21 Sep 2026

Pain during intrauterine device (IUD) placement often deters women from choosing this long-acting contraception. More...

Avoiding or undertreating procedural pain can reduce uptake and satisfaction with effective reproductive care. Researchers have now developed a simple intrauterine local anesthesia approach to make IUD insertion more tolerable. A new randomized clinical trial reports clinically meaningful reductions in pain and improved patient experience with this technique.

Karolinska Institutet (Stockholm, Sweden) evaluated intrauterine instillation of the local anesthetic mepivacaine delivered through a thin plastic catheter a few minutes before insertion. The technique targets the uterine cavity rather than cervical tissue and avoids needle injections. In usual practice, IUDs are placed without anesthesia or with a paracervical injection that itself can be painful.

The randomized clinical study enrolled 370 women aged 18 to 31 who had not previously given birth. Participants were assigned to receive either intrauterine mepivacaine or a saline placebo. Neither patients nor clinical staff knew which treatment was given.

Pain scores on a 0–100 scale averaged 43.8 with mepivacaine and 58.6 with placebo, a reduction of about 15 units. The share reporting the procedure as tolerable increased from 91.4% with placebo to 98.3% with mepivacaine. More than half of the treated group found insertion easier than expected, compared with about one third of controls. Most participants described the anesthetic administration itself as only mildly painful.

The trial was conducted across 11 gynecology clinics and youth health centers in Sweden. Outcomes were self-reported and the method was not compared directly with other analgesic strategies, which the investigators noted as limitations. The findings were published on September 17, 2026, in the JAMA. Some researchers reported lecture honoraria from intrauterine device makers, and those companies had no role in the study’s conduct or analysis.

“We can see that the method not only reduces pain, but also means that more people find the procedure acceptable,” said Helena Kopp Kallner, professor at the Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, and senior consultant at the Women's Clinic at Danderyd Hospital.

“It is a simple method that does not require needles and is easy to use in everyday clinical practice,” said lead author Karin Elgemark, a doctoral student at the Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet.

Related Links
Karolinska Institutet


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Patient Preoperative Skin Preparation
BD ChloraPrep
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Critical Care

view channel
Image: Tubes attached to this artificial lung are connected to the patient\'s neck or chest, allowing blood to circulate and get oxygen while the patient is conscious. (Image Credit: Carnegie MellonImage: Tubes attached to this artificial lung are connected to the patient\'s neck or chest, allowing blood to circulate and get oxygen while the patient is conscious. (Image Credit: Carnegie Mellon University)University)

Portable Artificial Lung Technology Could Reshape Care for Chronic Lung Disease

Chronic lung disease can leave patients dependent on prolonged mechanical ventilation or awaiting transplantation, both of which carry substantial morbidity and healthcare costs. Ventilatory support may... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.